See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Researchers have unveiled a breakthrough showing that a subset of ...
Circulating tumor DNA (ctDNA)—genetic material shed from tumors into the bloodstream—may help risk-stratify patients with Stage 3 colon cancer by tailoring chemotherapy options after surgery based on ...
Colon cancer diagnosis involves colonoscopy, imaging, and blood tests, with staging guiding treatment decisions. Stage 1 treatment typically involves surgery, while stage 2 may include chemotherapy ...
Underinvested, Under-Referred, and Underserved: Applying a Gender Equity Continuum Framework in Cancer Control Continuum Programs and Policies to Expand to Transgender and Nonbinary Populations Of 336 ...
Neoadjuvant chemotherapy did not improve disease-free survival compared with upfront surgery in patients with locally advanced colon cancer in a randomized trial. However, neoadjuvant chemotherapy did ...
Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced the peer-reviewed publication of updated results from the investigator-sponsored Phase 2 NEST trial evaluating ...
COMMIT: A Randomized Study of mFOLFOX6/Bevacizumab/Atezolizumab or Atezolizumab Alone as First-Line Treatment of Deficient DNA Mismatch Repair Metastatic Colorectal ...
Researchers have unveiled a breakthrough showing that a subset of colorectal tumors can be eliminated using immunotherapy alone, without chemotherapy or surgery. The finding signals a potential shift ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results